Ketamine Treatment for Amyotrophic Lateral Sclerosis
Copyright © Targeted News Service 2024
2024-10-29
ALEXANDRIA, Virginia, Oct. 29 -- UNIVERSITY OF KANSAS, Lawrence, Kansas has been assigned a patent (No. US 12128012 B2, initially filed May 14, 2021) developed by three inventors Richard Barohn, Kansas City, Missouri; John A. Stanford, Prairie Village, Kansas; and Matthew Macaluso, Wichita, Kansas, for "Ketamine treatment for amyotrophic lateral sclerosis." . . .